Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

• Main Authors: Matteo Lambertini (Author), François Richard (Author), Bastien Nguyen (Author), Giulia Viglietti (Author), Cynthia Villarreal-Garza (Author)
• Format: Book
• Published: SAGE Publishing, 2019-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Chemotherapy-induced premature ovarian insufficiency (POI) is one of the potential drawbacks of chemotherapy use of particular concern for newly diagnosed premenopausal breast cancer patients. Temporary ovarian suppression obtained pharmacologically with the administration of a gonadotropin-releasin...